Drugs

Predictors of Treatment Response in Chronic Hepatitis B
pp. 2167-2177(11)
Authors: Wong, Grace L.-H.; Chan, Henry L.-Y.

Enzyme Replacement Therapy for Fabry Disease: A Systematic Review of Available Evidence
pp. 2179-2205(27)
Authors: Schaefer, Roland M.; Tylki-Szymańska, Anna; Hilz, Max J.

Medical Therapy of Acromegaly: Efficacy and Safety of Somatostatin Analogues
pp. 2207-2226(20)
Authors: Feelders, Richard A.; Hofland, Leo J.; van Aken, Maarten O.; Neggers, Sebastian J.; Lamberts, Steven W.J.; de Herder, Wouter W.; >Aart-Jan van der Lely,

Immunosuppressive Drugs in Kidney Transplantation: Impact on Patient Survival, and Incidence of Cardiovascular Disease, Malignancy and Infection
pp. 2227-2243(17)
Authors: Marcén, Roberto

Tenofovir Disoproxil Fumarate: In Chronic Hepatitis B
pp. 2245-2256(12)
Authors: Perry, Caroline M.; Simpson, Dene

Palonosetron: In the Prevention of Nausea and Vomiting
pp. 2257-2278(22)
Authors: Yang, Lily P.H.; Scott, Lesley J.

Pemetrexed: A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer
pp. 2279-2302(24)
Authors: Baldwin, Claudine M.; Perry, Caroline M.

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer
pp. 2303-2328(26)
Authors: Sanford, Mark; Scott, Lesley J.

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease
pp. 2329-2349(21)
Authors: Curran, Monique P.; Robinson, Dean M.